Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Microbiota (FMT) Oral Capsules in the Treatment of Recurrent Clostridioides Difficile Infection

NCT07458984 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT07458984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07458984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Microbiota (FMT) Oral Capsules in the Treatment of Recurrent Clostridioides Difficile Infection
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
April 25, 2026
Completion date
December 31, 2030
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridioides difficile infection recurrence, fmt